ONCY - Oncolytics Biotech Inc. (ONCY) Q1 2024 Earnings Call Transcript
2024-05-09 20:48:02 ET
Oncolytics Biotech, Inc. (ONCY)
Q1 2024 Earnings Conference Call
May 09, 2024, 16:30 ET
Company Participants
Jon Patton - Director, Investor Relations and Communication
Matthew Coffey - President, CEO & Director
Thomas Heineman - Chief Medical Officer, Oncolytics Biotech (U.S.)
Kirk Look - CFO
Conference Call Participants
John Newman - Canaccord Genuity
Presentation
Operator
Good afternoon and welcome to Oncolytics Biotech's First Quarter 2024 Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Jon Patton, Director of Investor Relations and Communications. Please go ahead.
Jon Patton
Thank you, operator, and good afternoon, everyone. Earlier today, Oncolytics issued press release providing recent operational highlights and financial results for the first quarter of 2024. A replay of today's call will be available on the Events section of the Oncolytics website approximately two hours after its completion. After remarks from company management will open the call for Q&A.
As a reminder, various remarks made during this call contain certain forward-looking statements relating to the company's business prospects and the development and commercialization of pelareorep, including statements regarding the company's mission, company's belief as an essential and mechanism of action of pelareorep as a cancer therapeutic....
Oncolytics Biotech, Inc. (ONCY) Q1 2024 Earnings Call Transcript